◆ 会议时间：2021年7月25-29日
◆ 会议地点：虚拟会议-Digital Congress
◆ 会议简介：
2021年第28届国际生物力学学会(ISB)大会将于2021年7月25-29日以虚拟会议形式举行。
国际生物力学学会(ISB)于1973年8月30日在美国宾夕法尼亚州立大学成立，旨在促进国际层面对生物力学各领域的研究。ISB促进并支持科学家之间的国际联系、传播知识以及国家组织在生物力学领域的活动。ISB对生物力学的科学和应用有广泛的认识，认为生物力学在从整个生物体水平到分子尺度的所有生物系统的研究中宣都起着重要作用。ISB成员包括来自解剖学、生理学、工程学(生物医学、机械、机电一体化等)、骨科、康复医学、运动科学、运动医学、人体工程学、电生理运动学等各学科领域的科学家。国际生物力学学会(ISB)的主要活动是每两年召开一次ISB国际会议。——未经许可，禁止复制摘录转载本站任何内容-领域国际医学会议网。
XXVIII Congress of the International Society of Biomechanics (ISB)
The International Society of Biomechanics (ISB) in collaboration with The Swedish School of Sport and Health Sciences (GIH), the Royal Institute of Technology (KTH) and Karolinska Institute (KI) are looking forward to welcoming you to a fully digital congress on the 25-29 July 2021. All lectures will be held in English.
摘要提交截止日期：
The submission deadline is 31 January 2021. The deadline will not be extended.
点此提交摘要>>>Submit Abstract>>>
注册费：
ISB MEMBERS
Participant Member ISB Fee
Early bird until June 1 – SEK 2000 ex VAT
Regular fee from June 2 – SEK 2500 ex VAT
Student Member ISB Fee
Early bird until June 1 – SEK 750 ex VAT
Regular fee from June 2 – SEK 1250 ex VAT
NON MEMBERS
PARTICIPANT FEE
Early bird until Juni 1 – SEK 3000 ex VAT
Regular fee from June 2 – SEK 3500 ex VAT
STUDENT
FEE
Early bird until June 1 – SEK 1250 ex VAT
Regular fee from June 2 – SEK 1750 ex VAT
DEVELOPING COUNTRIES
Early bird until June 1- SEK 1000 ex VAT
Regular fee from June 2 – SEK 1500 ex VAT
STUDENTS DEVELOPING COUNTRIES
Early bird until June 1 – SEK 500 ex VAT
Regular fee from June 2 – SEK 750 ex VAT
Registration fees
The registration fee includes: attendance to all sessions & congress material.
Student fees
The student fee applies for all students enrolled in a recognized academic institution. To register students must be able to provide Student ID or similar documentation. PhD-students/PhD-candidates preparing for their PhD-degree are allowed to register as “Students”.
Included in the registration fee: Congress lectures & material.
◆ 参会对象：医生、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。
|
